Physician

Adeela Cheema, MD

According to 2025 Medicare claims, Adeela Cheema, MD (NPI: 1841680287) practices geriatric medicine in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is ENDEAVOR HEALTH MEDICAL GROUP (NPI: 1497701882; TIN: 363738206) and primary practice location at 60640-3007. Cheema is affiliated with the Rancho Health Management, LLC (ACO ID: D0015), participating under the REACH model.

Cheema's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 255 traditional Medicare patients, billed 1,224 HCPCS/CPT codes, and received $86,325 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 5,408 prescription claims across 572 beneficiaries totaling $693,752 in drug costs, led by Eliquis (Apixaban). DME data shows 45 claims. Open Payments data shows 65 records totaling $1,458. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $3,454 to $86,325. Similarly, Part D prescription costs have risen steadily, from $4,207 to $693,752. For DME billing, reported payments moved sharply higher in recent years, from $862 to $23,492.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	32	54	$3,454
2021	159	507	$41,500
2022	213	783	$63,193
2023	248	1,142	$93,655
2024	255	1,224	$86,325

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	46	113	$4,207
2016	54	199	$15,863
2017	57	291	$27,355
2018	64	482	$50,078
2019	12	51	$6,340
2020	45	101	$2,488
2021	188	869	$61,823
2022	362	3,004	$244,890
2023	471	4,242	$521,620
2024	572	5,408	$693,752

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	19	$314
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	21	$260
2023	11	29	$220
2024	12	45	$412

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	97	97	$136
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	188	319	$92
G0008	Administration of influenza virus vaccine	45	48	$34
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	121	179	$13
36415	Insertion of needle into vein for collection of blood sample	104	133	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	94	5,922	$113,318
Januvia	Sitagliptin Phosphate	53	4,220	$75,210
Ozempic	Semaglutide	49	1,936	$59,517
Myrbetriq	Mirabegron	57	3,090	$46,394
Farxiga	Dapagliflozin Propanediol	42	1,980	$34,225

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	12	27	$394
A4259	Lancets, per box of 100	N	N/R	18	$18

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	65	$1,458	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adeela Cheema, MD?

Tedicare shows public-source Medicare data for Adeela Cheema, MD (NPI 1841680287), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adeela Cheema, MD have ACO affiliation data?

Adeela Cheema, MD is shown with ACO affiliation data for Rancho Health Management, LLC (REACH, ACO ID D0015).

What billing organization is linked to Adeela Cheema, MD?

Adeela Cheema, MD is linked to ENDEAVOR HEALTH MEDICAL GROUP (billing NPI 1497701882) in the available physician profile data.

Does Adeela Cheema, MD have Open Payments data?

Adeela Cheema, MD has 65 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.